← all works
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Oncology
- Topic
- Cervical Cancer and HPV Research
- Field
- Medicine
- Canadian institutions
- McGill UniversityJewish General Hospital
- Funders
- —
- Keywords
- PlaceboMedicineDouble blindVirus-like particleHuman papillomavirusInternal medicineVirologyRecombinant DNAAlternative medicinePathologyBiology
- Has abstract in OpenAlex
- no